Understanding Manulife Financial – Key Insights

By Tamara Parker • Tuesday, June 02 10:54 • Permanent Link

Large-cap Finance company Manulife Financial has moved 2.1% so far today on a volume of 276,496, compared to its average of 2,248,122. In contrast, the S&P 500 index moved 0.0%.

Manulife Financial trades 11.94% away from its average analyst target price of $34.38 per share. The 2 analysts following the stock have set target prices ranging from $31.102835 to $37.648975, and on average have given Manulife Financial a rating of buy.

If you are considering an investment in MFC, you'll want to know the following:

Manulife Financial has moved 18.0% over the last year, and the S&P 500 logged a change of 27.3%
Based on its trailing earnings per share of 2.51, Manulife Financial has a trailing 12 month Price to Earnings (P/E) ratio of 15.3 while the S&P 500 average is 29.3
MFC has a forward P/E ratio of 10.8 based on its forward 12 month price to earnings (EPS) of $3.58 per share
The company has a price to earnings growth (PEG) ratio of 0.78 — a number near or below 1 signifying that Manulife Financial is fairly valued compared to its estimated growth potential
Its Price to Book (P/B) ratio is 1.83 compared to its sector average of 1.78
Manulife Financial Corporation, together with its subsidiaries, provides financial products and services in the United States, Canada, Asia, and internationally.
Based in Toronto, the company has 37,000 full time employees and a market cap of $64.22 Billion. Manulife Financial currently returns an annual dividend yield of 4.8%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.